News
4h
Audacy on MSNMerck invests $1B in Wilmington facility to boost U.S. drug production amid tariff concernsU.S. drug maker Merck is building a $1 billion facility in Wilmington, Delaware, aimed at increasing domestic production of ...
In its trade war with Donald Trump, China has slapped on tariffs as high as 150% on imports. The affected vehicles include the F-150 Raptor, Mustang, Bronco and Lincoln Navigator. Ford continues ...
EconoTimes is a global, independent publication that delivers comprehensive news, analysis, and insights on the economy, finance, and markets. Based in Korea, we offer a unique perspective on global ...
EconoTimes is a global, independent publication that delivers comprehensive news, analysis, and insights on the economy, finance, and markets. Based in Korea, we offer a unique perspective on global ...
Dr. Tedros Adhanom Ghebreyesus declares the end of the COVID-19 pandemic, highlighting global vaccination efforts and future ...
AstraZeneca has announced the Positive high-level results from the Phase III KALOS and LOGOS trials in patients with ...
AstraZeneca’s fixed-dose triple-combination therapy, Breztri meets primary endpoints in KALOS & LOGOS phase III trials in asthma: Cambridge, UK Saturday, May 3, 2025, 10:00 Hrs ...
Positive results from the Phase III KALOS and LOGOS trials show that AstraZeneca's Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumar ...
AstraZeneca Plc (NASDAQ:AZN) reported topline data from Phase 3 KALOS and LOGOS trials in patients with uncontrolled asthma.
Akeso's first overall survival readout for its Keytruda challenger caused a violent market reaction. AstraZeneca disclosed ...
AstraZeneca announced on Friday that its inhaled triple-combination therapy ‘Breztri Aerosphere’ met all primary endpoints in ...
French nationals head about 30 major foreign companies whose total market capitalization amounts to $2 trillion. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results